The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial

By sjmartinez • April 27, 2025

Golub LS, Manubolu VS, Aldana-Bitar J, Dahal S, Verghese D, Alalawi L, Krishnan S, Kianoush S, Benzing T, Ichikawa K, Kinninger A, Fazlalizadeh H, Pourafkari L, Ahmad K, Susarla S, Mangaoang C, Ghanem AK, Javier DA, Hamal S, Roy SK, Budoff MJ. The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial. Nutr Metab Cardiovasc Dis. 2025 Apr 5:104036. doi: 10.1016/j.numecd.2025.104036. Epub ahead of print. PMID: 40287313.

Tags: ASCVD, atherosclerotic cardiovascular disease, CAC, Cardiology/Epi, cardiovascular disease, Computed Tomography Angiography, coronary artery calcium, CTA, CVD, General Internal Medicine, GLP1 receptor agonists, Harbor UCLA, HCC, Hepatocellular carcinoma, MASH, MASLD, Metabolic dysfunction-associated Steatohepatitis, Metabolic dysfunction-associated steatotic liver disease, Publications, randomized trial, Resident, semaglutide

Simultaneous or Rapid Sequence Optimization of Medical Therapy for Heart Failure: Time to Keep Score

Shoji S, Fonarow GC, Greene SJ. Simultaneous or Rapid Sequence Optimization of Medical Therapy for Heart Failure: Time to Keep Score. Circ Heart Fail. 2025[...]

Oxy210 Inhibits Hepatic Expression of Senescence-Associated, Pro-Fibrotic, and Pro-Inflammatory Genes in Mice During Development of MASH and in Hepatocytes In Vitro

Wang F, Hui ST, Stappenbeck F, Kaminska D, Lusis AJ, Parhami F. Oxy210 Inhibits Hepatic Expression of Senescence-Associated, Pro-Fibrotic, and Pro-Inflammatory Genes in Mice During[...]

The evolving risk of infective endocarditis after transcatheter aortic valve implantation

Alabbadi SH, Iribarne A, Rodés-Cabau J, Doenst T, Chikwe J, Itagaki S, Toyoda N, Makkar R, Akowuah EF, Perez M, Bandettini WP, Akhter SA, Bleiziffer[...]